Activist shareholder Carl Icahn wants access to documents related to the biotech's attempts at a sale last fall.
04:53PM 05/21/08
Acquisition Charges Hit Celgene
But the biotech beats Wall Street estimates on an adjusted basis, when factoring out expenses related to Pharmion.
10:18AM 05/08/08
Biotech Notebook: Glaxo, Wyeth, Spectrum
How the Glaxo buy of Sirtris fits a recent mould; reading into Spectrum Pharma's data for ozarelix.
10:36AM 04/23/08
First-quarter earnings and revenue are better than expected, and full-year outlook rises.
10:46AM 04/15/08
Feuerstein's Biotech-Stock Mailbag
The latest M&A and what it means more broadly; tapping Russia for drug approvals; the next potential insulin play and more.
10:19AM 04/12/08
Fast Money 'Pops and Drops': Amgen Hangs Tough
The panel says the pharma company was right to stand up for its anemia patent.
06:55PM 04/10/08
Thursday's Winners & Losers: Millennium Pharmaceuticals
Shares rise 48.9% on news of a buyout.
04:36PM 04/10/08
Don't Dismiss Oil, Agriculture Stocks (RealMoney.com $)
Stocks in these sectors are good, solid plays that aren't expensive on a multiple basis.
04:27PM 04/10/08
Hong Kong Stocks Rise, but Tokyo Falls
The Shanghai Composite Index gains 57.84 points, or 1.7%, to 3471.74.
01:09PM 04/10/08
Japan's Takeda Will Pay $9B for Millennium
The largest overseas acquisition by a Japanese drug maker comes at a 53% premium to Millennium's Wednesday close.
07:05AM 04/10/08
Cramer's 'Mad Money' Recap: H&R Block's Turnaround
The company is clobbering the competition and making smart moves, Cramer says.
07:50PM 03/19/08
'Mad Money Lightning Round': Ring Up AT&T
Cramer advises buying the telecom giant at $35 a share.
07:27PM 03/19/08
Connect with TheStreet